Posted in | News | Chemical Sensor

Smiths Detection Supplies Explosives Trace detection Technology to TSA

The Transportation Security Administration (TSA) has placed an order worth $11.4 million to Smiths Detection for the supply of the IONSCAN 500DT, the Smith’s explosives trace detection technology.

This order is a follow-up of an earlier order worth $6 million placed by the TSA during October 2008.

Smiths Detection explosives trace detection technology the IONSCAN 500DT

Smiths Detection’s VP of Homeland Security, Mark Laustra, informed that Smiths is pleased to continue its tie-up with TSA by offering dependable explosives detection systems. He explained that the IONSCAN 500DT’s sensitivity offers high detection level and helps TSA to continue adopting the multilayered security approach.

The desktop detectors are utilized at security checkpoints for identifying trace quantities of explosives that are gathered within seconds on a single swab.

The ion mobility spectrometry technology is used by the IONSCAN 500DT in a dual tube design for offering the requisite high accuracy and sensitivity required for detection of trace explosives. By virtue of its detection speed and small size, this system is useful for applications relating to checkpoint security screening in courthouses, private buildings, airports, public, borders, ports, correctional, borders, and air cargo screening facilities.

Smiths Detection has so far deployed more than 6,000 desktop trace detection solutions, besides its industry-best X-ray inspection systems and various detectors placed in about 80 percent of the airports in the world.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.